Please assess the completion status of the following clinical trial:

Trial Title: Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients ASA I-III~* Between 18 - 80 years old~* Scheduled for routine cervical surgery~* Minimum duration of surgery is 90 minutes and performed with total intravenous anaesthesia (TIVA) with the hypnotic propofol, the analgesic remifentanil and the neuromuscular relaxant rocuronium~* Patients that are able to and do provide a signed informed consent form~Exclusion Criteria:~* Patients with neuromuscular diseases and severe cardiac and respiratory pathologies~* Contra indication for any of the drugs used~* Not able to complete the baseline PQRS test.~* Indication to perform tracheal intubation using fibroscopy~* Patients who are pregnant or nursing

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Standard Group (Type: NO_INTERVENTION): Standard Clinical Practice Group - standard neuromuscular block, with a standard rocuronium dose for intubation (0.6 mg/kg). If required, the reversal of neuromuscular block is performed with neostigmine.
- Deep NMB group (Type: EXPERIMENTAL): Deep Neuromuscular Block group - with a standard rocuronium dose for intubation (0.6 mg/kg), followed by a constant infusion of rocuronium (10-15 ug/kg/min) to guarantee a PTC less or equal to 2 on the TOF monitor (PTC is evaluated every 5 minutes). The reversal of neuromuscular block is performed with Sugammadex (4 mg/kg).

Based on this trial design, predict the completion outcome and termination type (if applicable).